Sodium Zirconium Cyclosilicate

5 trials 3 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

2 Completed trials

5 Sponsors

6 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Indications tested

Hyperkalaemia 1

Sponsors using this IMP

Academisch Ziekenhuis Leiden 1 AstraZeneca AB 1 Hospital Clinico Universitario De Valencia 1 Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA 1 Vaestra Goetalandsregionen 1

All trials

5 total

A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd ch… Recruiting

2024-513971-42-00 Phase III 1 country Hospital Clinico Universitario De Valencia
Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to s… Recruiting

2024-517631-43-00 Phase III 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…
An open-label study to assess safety and efficacy of SZC in paediatric patients with hyperkalaemia Recruiting

2023-508455-38-00 Phase III 4 countries AstraZeneca AB
LIBERAL Study Ended

2023-507823-52-00 Phase III 1 country Academisch Ziekenhuis Leiden
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF) Ended

2024-511502-24-02 Phase II 1 country Vaestra Goetalandsregionen

Showing 1–5 of 5 trials

← All drugs A–Z